POSTER SESSION VI Wednesday, March 02, 2005   —  1:00 - 4:00 PM Convention Center, Exhibit Hall B GASTROINTESTINAL PATHOLOGY 77 Outcome in Patients with Colorectal Adenocarcinoma in Relation to the Expression of the Growth Factor Pleiotrophin and Its Receptor Anaplastic Lymphoma Kinase (482) RT Henke, SE Kim, WJ Fang, A Maitra, A Wellstein - Georgetown University, Washington, DC; Johns Hopkins University, Baltimore, MD 78 A Novel Set of Suppressor Genes (RSK4, KIA0828, tip60) Are Highly Downregulated in Colon and Lung Carcinomas (504) M Lleonart, L Lopez, F Rojo, M Cuatrecasas, C Iglesias, J Majo, R Bernards, S Ramon y Cajal - Vall d'Hebron University Hospital, Barcelona, Spain; The Netherlands Cancer Institute, Netherlands 79 Glucose Transporter 1 (GLUT-1) Expression and Cellular Localization in Early Colorectal Neoplasia (442) S Bakheit, J Dolan, J O'Sullivan, G Keating, J Gorman, H Mulcahy, J Hyland, D O'Donoghue, K Sheahan - St Vincents University Hospital, Elm Park, Dublin 4, Ireland; University College Dublin, Dublin, Ireland 80 Expression of Claudin 7 and Sox-4 in Gastric and Colorectal Adenocarcinomas (535) E Rudzinski, RJ Coffey, B LaFleur, JR Goldenring, P Wirth, A Frazier, K Washington - Vanderbilt University Medical Center, Nashville, TN 81 Expression of Erythropoietin and Its Receptor Increases in Colonic Neoplastic Progression: The Role of Hypoxia in Carcinogenesis (475) Z Gombos, K Heightchew, G Acs, M Chen, EE Furth - University of Pennsylvania Medical Center, Philadelphia, PA 82 Genomic Gains on Chromosome 8q and Prognosis of Stage 2 Colonic Adenocarcinoma: An Array-Based Comparative Genomic Hybridization (A-CGH) and Fluorescence In Situ Hybridization (FISH) Study (543) M Skacel, DP Gaile, AA Siva, J Conroy, N Nowak, JR Goldblum, I Lavery, G Casey, MP Bronner, RR Tubbs - Cleveland Clinic Foundation, Cleveland, OH; Roswell-Park Cancer Institute, Buffalo, NY 83 Immunohistochemical Expression of the PPM1D/wip-1 Protein Correlates with Aggressive Tumor Behavior in Invasive Colorectal Carinomas (CRCS) (479) DP Hartmann, BVS Kallakury, J Luka, EA Appella, G Owor, DM Jones, CE Sheehan, N Azumi, JS Ross - Georgetown University Hospital, Washington, DC; Trevigen Inc, Gaithersburg, MD; GRS/NIH, Bethesda, MD; Albany Medical College, Albany, NY 84 Expression of Matrix Metalloproteinases (MMP) 2 and 9 in Colorectal Adenocarcinoma (521) G Owor, J Malysz, HW Lee, D Eldeiry, JS Ross, DM Jones - Albany Medical College, Albany, NY 85 RACK1 Overexpression Associates with High Grade and Lymph Node Metastases in Colorectal Carcinomas: A Preliminary Study (455) M Cuatrecasas, P Espinoza, C Iglesias, F Rojo, J Tabernero, S Ramon y Cajal - Vall d'Hebron University Hospital, Barcelona, Spain 86 Colorectal Carcinomas Lacking MGMT Immunohistochemical Expression Display a Peculiar Clinicopathologic Profile (451) AM Chiaravalli, S Orsatti, D Furlan, I Carnevali, C Capella - Ospedale di Circolo; University of Insubria, Varese, Italy 87 Prognostic Significance of COX-2 and VEGF Expression in Human Rectal Cancer Treated with Pre-Operative Radiotherapy (461) I de Torres, B Navalpotro*, J Giralt*, F Rojo, J Majo, S Ramon y Cajal - Vall de Hebron University Hospital, Barcelona, Catalunya, Spain 88 Cox-2 Expression in Microsatellite Unstable Colorectal Cancer. Differences Regarding MLH1 and MSH2 Loss of Expression (435) C Alenda, A Payá, FI Aranda, FM Peiró, M Niveiro, G Peiró, L Crespo, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association - Hospital General Universitario de Alicante, Alicante, Spain 89 Absent or Low Expression of CK20 and CDX2 Associated with Microsatellite Instability in Poorly Differentiated Colorectal Carcinomas (PDCC) (567) SB Zhu, C Schuerch, F Lin - Geisinger Medical Center, Danville, PA 90 Loss of CDX2 Expression Correlates with Clinicopathologic Features in Colorectal Cancers (441) YK Bae, JH Choi, MJ Kim, MG Jung Yeungnam - University Medical Center, Daegu, Korea; Yeungnam University Medical Center, Daegu, Korea 91 CDX-2 Is Specific for Intestinal-Type Differentiation: A Tissue Microarray Based Study of 629 Tumors from Different Sites (459) LB De Lott, C Morrison, S Suster, DE Cohn, WL Frankel - Ohio State University, Columbus, OH 92 Differential Expression of Mucins (MUC1, MUC2, MUC4, MUC5AC and MUC6) in Microsatellite Stable and Unstable Colorectal Cancers and Correlation with CDX-2 (460) LB De Lott, WM Smith, P Wen, A Lehman, H Hampel, A de la Chapelle, WL Frankel - Ohio State University, Columbus, OH 93 Mucin Profiling in Signet-Ring Cell Carcinomas (516) M Nguyen, WL Frankel, B Plasil, P Wen - Ohio State Univeristy Medical Center, Columbus, OH 94 Microsatellite Stable and Unstable Mucinous Colorectal Adenocarcinomas Show Similar Expression Profiles for MUC1, MUC2, MUC4 and MUC5AC but Differ in MUC6 (510) K Merati, P Wen, LB De Lott, H Hampel, A de la Chapelle, WL Frankel - Ohio State University, Columbus, OH 95 Clinicopathologic Characteristics, Microsatellite Instability, Mucin Core Protein and p53 Protein Expression of Colorectal Mucinous Adenocarcinomas in Relation to Location (524) S Park, H Lee, J Chung, G Choe, W Kim - Seoul National University Bundang Hospital, Seongnam, Gyeonggi, Republic of Korea; Seoul National Uiversity College of Medicine, Seoul, Republic of Korea 96 Evaluation of Microsatellite Instability, hMLH1 Expression and hMLH1 Promoter Hypermethylation in 176 Colorectal Carcinomas (489) YN Kang, SY Kwon, SP Kim, KY Kwon, SS Lee - Keimyung University School of Medicine, Daegu, Korea 97 MBD2 in Colon Cancer and Its Association with DNA Methylation (539) RL Shen, MA Pereira, LH Tao - Ohio State University, Columbus, OH